Direct-To-Consumer (DTC) Genetic Testing Market 2024 – Business Revenue, Trends, Top Key Players, Future Opportunities, Industry Share And Forecast To 2033

Global direct-to-consumer (dtc) genetic testing market size is expected to reach $3.32 Bn by 2028 at a rate of 16.1%, segmented as by type, carrier testing, predictive testing, ancestry and relationship testing, nutrigenomic testing, other types

Share this Post to earn Money ( Upto ₹100 per 1000 Views )


Direct-To-Consumer (DTC) Genetic Testing Market 2024 – Business Revenue, Trends, Top Key Players, Future Opportunities, Industry Share And Forecast To 2033

Overview and Scope

Direct-to-consumer genetic testing involves the marketing of genetic tests directly to consumers through media such as radio, television, print adverts, and the internet, where customers can purchase the tests through online marketplaces and pharmacies. After purchasing a test kit, clients give the business a DNA sample and provide individuals access to their genetic data without necessarily requiring the involvement of a healthcare professional or health insurance provider via a secure website, app, or written report with their results.

 

Sizing and Forecast

The direct-to-consumer (DTC) genetic testing market size has grown rapidly in recent years. It will grow from $1.57 billion in 2023 to $1.83 billion in 2024 at a compound annual growth rate (CAGR) of 16.6%.  The growth in the historic period can be attributed to curiosity about ancestry and heritage, health and wellness trends, marketing and consumer education, privacy and control over genetic data, affordability and accessibility.

 

The direct-to-consumer (DTC) genetic testing market size is expected to see rapid growth in the next few years. It will grow to $3.32 billion in 2028 at a compound annual growth rate (CAGR) of 16.1%.  The growth in the forecast period can be attributed to expanding test offerings, integration with personalized medicine, collaborations with health and wellness industries, advancements in genetic research, government support and regulations. Major trends in the forecast period include expanding test offerings and panels, educational initiatives for consumers, regulatory compliance and oversight, genomic data research and contributions, price reduction and accessibility.

 

Order your report now for swift delivery, visit the link:

https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

 

Segmentation & Regional Insights

The direct-to-consumer (DTC) genetic testing market covered in this report is segmented –

1) By Type: Carrier Testing, Predictive Testing, Ancestry And Relationship Testing, Nutrigenomic Testing, Other Types

2) By Sample: Saliva, Urine, Blood

3) By Technology: Single Nucleotide Polymorphism Chips, Whole Genome Sequencing, Targeted Analysis

4) By Business Model: Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model, Restricted Trait Tests Mode

5) By End User: Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centers, Home Care, Cosmetics, Other End-User

 

North America was the largest region in the direct-to-consumer (DTC) genetic testing market share in 2023. Asia-Pacific was the second-largest region in the global direct-to-consumer (DTC) genetic testing market. The regions covered in the direct-to-consumer (dtc) genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

 

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8957&type=smp

 

Major Driver Impacting Market Growth

The rising prevalence of diseases and disorders with genetic transmission capabilities is expected to propel the growth of the direct-to-consumer (DTC) genetic testing market going forward. Genetic disorder refers to an illness caused by changes (mutation) in a person's DNA and it includes single-gene, multifactorial and chromosomal disorders. Direct-to-consumer genetic testing promotes awareness of various genetic disorders that helps in making predictions about health and provides personalized information about an individual’s health, disease risk, and other traits, thus, helps in taking effective health and lifestyle decisions to reduce the disease risk. For instance, according to MedlinePlus, a US-based online information service provided by the United States National Library of Medicine, in 2021, syndrome A is identified in about 1 in 200,000 Americans each year and currently around 100,000 kids suffer from syndrome B, whereas, it is estimated that nearly 12,000 people died globally from syndrome C in 2020 and approximately 1% of people in the United States develop disorder D during their lifetimes. Furthermore, in February 2022, according to the World Health Organization (WHO), a Switzerland-based agency of the United Nations responsible for international public health, birth abnormalities cause 240,000 new-borns to pass away in the first 28 days of life each year and an additional 170,000 children between the ages of 1 month and 5 years die as a result of birth abnormalities which includes heart defects, neural tube defects, and Down syndrome (a genetic disorder). Therefore, the rising prevalence of diseases and disorders with genetic transmission capabilities is driving the growth of the direct-to-consumer (DTC) genetic testing market.

 

Key Industry Players

Major companies operating in the direct-to-consumer (DTC) genetic testing market report are Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Konica Minolta, Inc., Genesis HealthCare, Inc., Ancestry.com LLC, Myriad Genetics, Inc., Fulgent Genetics, Inc., Sonora Quest Laboratories LLC, Prenetics Limited, 23andMe Holding Co., Color Health Inc., Living DNA Limited, MyHeritage Ltd., Victorian Clinical Genetics Services, Dante Labs S.r.l., Helix OpCo LLC, Gene by Gene, Ltd., Gene by Gene, Ltd., EasyDNA Ltd., Pathway Genomics Corporation, Full Genomes Corporation, Identigene LLC, Mapmygenome Labs Pvt. Ltd., Positive Bioscience Inc., Xcode Life Sciences Private Limited, 24Genetics S.L., Direct Laboratory Services, LLC, Karmagenes SA, Request A Test Ltd., Any Lab Test Now, LLC

 

The direct-to-consumer (dtc) genetic testing market report table of contents includes:

1. Executive Summary

2. Direct-To-Consumer (DTC) Genetic Testing Market Characteristics

3. Direct-To-Consumer (DTC) Genetic Testing Market Trends And Strategies

4. Direct-To-Consumer (DTC) Genetic Testing Market - Macro Economic Scenario

5. Global Direct-To-Consumer (DTC) Genetic Testing Market Size and Growth

.......................................

32. Global Direct-To-Consumer (DTC) Genetic Testing Market Competitive Benchmarking

33. Global Direct-To-Consumer (DTC) Genetic Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Direct-To-Consumer (DTC) Genetic Testing Market

35. Direct-To-Consumer (DTC) Genetic Testing Market Future Outlook and Potential Analysis

36. Appendix

 

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info 

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model